SG Americas Securities LLC Sells 3,831 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

SG Americas Securities LLC lessened its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 65.8% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,987 shares of the medical instruments supplier's stock after selling 3,831 shares during the period. SG Americas Securities LLC's holdings in ICU Medical were worth $362,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of ICUI. Motco bought a new position in ICU Medical in the 1st quarter worth about $29,000. Innealta Capital LLC bought a new position in ICU Medical in the 2nd quarter worth about $32,000. GAMMA Investing LLC boosted its stake in ICU Medical by 75.1% in the 1st quarter. GAMMA Investing LLC now owns 310 shares of the medical instruments supplier's stock worth $33,000 after purchasing an additional 133 shares in the last quarter. EntryPoint Capital LLC boosted its stake in ICU Medical by 731.5% in the 1st quarter. EntryPoint Capital LLC now owns 449 shares of the medical instruments supplier's stock worth $48,000 after purchasing an additional 395 shares in the last quarter. Finally, Russell Investments Group Ltd. boosted its stake in ICU Medical by 46.4% in the 1st quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier's stock worth $59,000 after purchasing an additional 173 shares in the last quarter. Institutional investors own 96.10% of the company's stock.

ICU Medical Stock Performance

ICU Medical stock traded up $0.43 during midday trading on Friday, hitting $180.94. The stock had a trading volume of 178,457 shares, compared to its average volume of 280,037. The firm's fifty day moving average is $170.09 and its two-hundred day moving average is $132.27. The company has a market capitalization of $4.41 billion, a PE ratio of -73.85 and a beta of 0.66. ICU Medical, Inc. has a 52-week low of $78.28 and a 52-week high of $188.53. The company has a current ratio of 2.41, a quick ratio of 1.08 and a debt-to-equity ratio of 0.76.

ICU Medical (NASDAQ:ICUI - Get Free Report) last released its earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.56. The company had revenue of $596.50 million during the quarter, compared to analyst estimates of $556.64 million. ICU Medical had a negative net margin of 3.07% and a positive return on equity of 5.01%. The firm's quarterly revenue was up 8.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.58 EPS. On average, research analysts forecast that ICU Medical, Inc. will post 3.76 EPS for the current year.

Analyst Ratings Changes

Several equities analysts have issued reports on the stock. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research note on Thursday, October 10th. KeyCorp upped their price target on shares of ICU Medical from $147.00 to $198.00 and gave the company an "overweight" rating in a research report on Tuesday. Raymond James upped their price target on shares of ICU Medical from $158.00 to $190.00 and gave the company an "outperform" rating in a research report on Thursday, September 12th. StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Thursday, September 12th. Finally, Jefferies Financial Group assumed coverage on shares of ICU Medical in a research report on Monday, October 14th. They set a "hold" rating and a $183.00 price target for the company. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, ICU Medical currently has an average rating of "Moderate Buy" and an average target price of $170.25.

Insider Buying and Selling at ICU Medical

In other ICU Medical news, VP Virginia Ruth Sanzone sold 2,050 shares of the stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $144.11, for a total transaction of $295,425.50. Following the completion of the sale, the vice president now directly owns 4,482 shares of the company's stock, valued at $645,901.02. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other ICU Medical news, CEO Vivek Jain sold 12,000 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $178.46, for a total transaction of $2,141,520.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at $18,665,666.78. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Virginia Ruth Sanzone sold 2,050 shares of the stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $144.11, for a total transaction of $295,425.50. Following the sale, the vice president now directly owns 4,482 shares of the company's stock, valued at approximately $645,901.02. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 40,552 shares of company stock valued at $6,679,322 in the last three months. 6.70% of the stock is currently owned by corporate insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.